| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/23/2007 | EP1109926B1 Condensed plasmid-liposome complex for transfection |
| 05/23/2007 | EP0873407B1 Apo-2 ligand |
| 05/23/2007 | EP0820469B1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 05/23/2007 | CN1969032A Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof |
| 05/23/2007 | CN1968965A Phosphorylcholine conjugates and corresponding antibodies |
| 05/23/2007 | CN1968716A Methods of treating lung diseases |
| 05/23/2007 | CN1968715A Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| 05/23/2007 | CN1968714A Lipids, lipid complexes and use thereof |
| 05/23/2007 | CN1968703A Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase |
| 05/23/2007 | CN1968701A Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin D or a derivative thereof |
| 05/23/2007 | CN1968683A Pharmaceutical compositions comprising an amphiphilic starch |
| 05/23/2007 | CN1968681A Pressurized foaming composition for topical treatment of psoriasis |
| 05/23/2007 | CN1968678A External preparation for the skin |
| 05/23/2007 | CN1966547A Double-chain structured polyethylene glycol derivative preparation and its combination with pharmaceutical molecule |
| 05/23/2007 | CN1966528A PEG-W conjugate linked by urea alkyl bond and its preparation method |
| 05/23/2007 | CN1966527A Polyethylene glycol-interferon coupler and its preparation method |
| 05/23/2007 | CN1966525A Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/23/2007 | CN1966097A Core/shell type polyurethane magnetic compound microsphere, preparation method and use thereof |
| 05/23/2007 | CN1966084A Double-stranded RNA oligonucleotides which inhibit tyrosinase expression |
| 05/23/2007 | CN1966077A Orally administered vaccine of hepatitis E and preparation process thereof |
| 05/23/2007 | CN1966072A Orally administered enteric-coated composition of calcitonin and preparation method thereof |
| 05/23/2007 | CN1966068A Transfer factor solution containing cluster water used for animals |
| 05/23/2007 | CN1965892A Liquid formulation for treating allergic rhinitis |
| 05/23/2007 | CN1965867A Method for preparing coating particles for lowering moisture-absorption of Chinese medicine extract |
| 05/23/2007 | CN1965866A Method for relieving bitter taste in compound Chinese medicine |
| 05/23/2007 | CN1965859A Sodium selenite solution containing clustered water used for animal |
| 05/23/2007 | CN1965857A Eye drop of povidone iodine and preparation process thereof |
| 05/23/2007 | CN1965852A Aloeresin D and effective component, preparation process, pharmaceutical composition and use thereof |
| 05/23/2007 | CN1965847A Amikacin solution containing clustered water used for animal |
| 05/23/2007 | CN1965846A Neomycin sulphate solution containing clustered water used for animal |
| 05/23/2007 | CN1965845A Drop pills of ginsenoside monomer and preparation process thereof |
| 05/23/2007 | CN1965842A Intra-uterus administered medicinal stick of danazol and preparation process thereof |
| 05/23/2007 | CN1965837A Ofloxacin solution containing clustered water used for animal |
| 05/23/2007 | CN1965836A Oral solid formulation and its preparation method |
| 05/23/2007 | CN1965835A Sarafloxacin hydrochloride solution containing clustered water used for animal |
| 05/23/2007 | CN1965834A Enrofolxacn solution containing clustered water used for animal |
| 05/23/2007 | CN1965829A Injection of palonosetron and preparation process thereof |
| 05/23/2007 | CN1965828A Danofloxacin mesylate solution containing clustered water used for animal |
| 05/23/2007 | CN1965827A Difloxacin hydrochloride solution containing clustered water used for animal |
| 05/23/2007 | CN1965820A Lipid microsphere, lyophilized lipid microsphere containing docetaxel and preparation process thereof |
| 05/23/2007 | CN1965819A Nanoemulsion of aceclofenac for treating rheumatoid arthritis and preparation process thereof |
| 05/23/2007 | CN1965817A Sustained release tablet of glibenclamide and preparation process thereof |
| 05/23/2007 | CN1965810A Sustained release microsphere formulation of thymosin alpha-1, preparation process and use thereof |
| 05/23/2007 | CN1965809A Sustained-release microsphere of LHRH antagonist for injection and preparation process thereof |
| 05/23/2007 | CN1965808A Self-emulsifying composition of beta-11 betamethasone, preparation process and application thereof |
| 05/23/2007 | CN1965807A Fat emulsion injection prepared by using saturated fatty acid lecithin |
| 05/23/2007 | CN1965803A Non-aerosol type composition for foaming agent and foaming agent using the composition |
| 05/23/2007 | CN1965802A Injectable hydrogel preparation of pegylated medicament |
| 05/23/2007 | CN1317303C Anti-human tenascin monoclonal antibody |
| 05/23/2007 | CN1317288C Method for producing tablet, baked product or chewing gum |
| 05/23/2007 | CN1317035C Method for assembling multi-biological functional factor on micro-particle surface based on hydrazide group |
| 05/23/2007 | CN1316977C Stabilized brivudine topical formulations |
| 05/23/2007 | CN1316973C Beta-carotene clathrate and its preparation method |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220853 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 05/22/2007 | US7220840 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 05/22/2007 | US7220836 Dried blood factor composition comprising trehalose |
| 05/22/2007 | US7220767 Pharmaceutical formulations containing zolmitriptan |
| 05/22/2007 | US7220762 Methods for stabilizing benzimidazole compounds |
| 05/22/2007 | US7220726 Antifungal pimaricin compositions and therapeutic methods employing same |
| 05/22/2007 | US7220551 Vaccine containing human papillomarus virus antigen, aluminum hydroxide and a preferential stimulator of TH1 cell response such as 3 De-O-acylated monophosphoryl lipid A (3D-MPL) |
| 05/22/2007 | US7220545 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
| 05/22/2007 | US7220434 Dual-release compositions of a cyclooxygenase-2 inhibitor |
| 05/22/2007 | US7220433 Microparticle with drug, peptide or protein core encapsulated by first biodegradable, insoluble, and solvent-impervious polymer film of starch, sugars, polyvinyl alcohol, gelatin, glycols, or cellulose; other films of hydroxypropyl methyl cellulose or poly(monostearoyl glycerol-co-succinate) |
| 05/22/2007 | US7220428 Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells |
| 05/22/2007 | US7220427 Mixture for transdermal delivery of low and high molecular weight compounds |
| 05/22/2007 | US7220424 For topical application, penetration |
| 05/22/2007 | US7220420 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 05/22/2007 | US7220414 For use in pharmaceutical and biomedical applications, stability; conjugates of polymers with drugs anticancer drugs used in cancer therapy |
| 05/22/2007 | US7220403 Pharmaceutical formulation of fluticasone propionate |
| 05/22/2007 | US7220401 To deliver a radionuclide to a blood clot, to obtain an ultrasound image of a blood clot, for diagnosis, therapy |
| 05/22/2007 | US7220399 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 05/22/2007 | CA2341303C Gelatinous body protection article having a therapeutic effect |
| 05/22/2007 | CA2323680C Orally disintegrable tablets |
| 05/22/2007 | CA2307632C Aqueous liquid pharmaceutical composition |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2266718C Polysaccharide conjugates of biomolecules |
| 05/22/2007 | CA2227443C Granular preparation and producing process thereof |
| 05/22/2007 | CA2208241C Stable solutions of 2-chloro-2'-deoxyadenosine formulations |
| 05/22/2007 | CA2206736C Aerosol formulations of peptides and proteins |
| 05/22/2007 | CA2187353C Liquid delivery compositions |
| 05/22/2007 | CA2186133C Retinal-containing composition |
| 05/22/2007 | CA2156922C Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
| 05/18/2007 | WO2007056307A2 Appetizer supplement to suppress age-related decline in capacity and appetite |
| 05/18/2007 | WO2007056279A2 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors |
| 05/18/2007 | WO2007056205A2 Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents |
| 05/18/2007 | WO2007056153A2 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
| 05/18/2007 | WO2007055950A2 Polycation-polyanion complexes, compositions and methods of use thereof |
| 05/18/2007 | WO2007055428A1 Intraorally rapidly disintegrating tablet |
| 05/18/2007 | WO2007055427A1 Intraorally rapidly disintegrating tablet |
| 05/18/2007 | WO2007055329A1 Controlled release solid preparation |
| 05/18/2007 | WO2007055327A1 Jelly composition |
| 05/18/2007 | WO2007055279A1 Iontophoresis preparation |
| 05/18/2007 | WO2007055176A1 Pressure-sensitive adhesive base and adhesive patch of percutaneous absorption type |
| 05/18/2007 | WO2007055105A1 Novel anthocyanin compound and method for producing same |
| 05/18/2007 | WO2007055044A1 Promoter for recovery from anesthesia |
| 05/18/2007 | WO2007054976A2 Lipid based controlled release pharmaceutical composition |
| 05/18/2007 | WO2007054958A1 A stable formulation for treatment of respiratory disorder |
| 05/18/2007 | WO2007054782A1 Stabilized lanthanum carbonate compositions |
| 05/18/2007 | WO2007054373A1 Composition and its use for the manufacture of a medicament for treating, prophylactically treating, preventing cancer and/or infections in the urinary tract |